PERHAPS A GIFT VOUCHER FOR MUM?: MOTHER'S DAY

Close Notification

Your cart does not contain any items

Cutaneous Lymphomas

Unusual Cases 3

Oleg E. Akilov

$130.95   $105.07

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Springer Nature Switzerland AG
02 April 2022
This book provides a current experience in the diagnostic techniques and treatment approaches available for unusual cutaneous lymphomas. It features concise case-based chapters with a particular emphasis on instances of mature T-cell and NK-cell neoplasms, mature B-cell neoplasms, immature hematopoietic malignancies, and other lymphoproliferative disorders. Clinically-oriented cases emphasize the importance of physical examination along with modern tests of laboratory diagnostics and clinico-pathological correlations.

Cutaneous Lymphomas: Unusual Cases 3 presents a range of difficult and rare cases, which would be uncommon even to the specialists in this field. Therefore, it is a vital reference source for dermatologists, dermatophatologists, cutaneous oncologists, hematooncologists, pathologists, oncologists, and other medical professionals who treat these patients.

Edited by:  
Imprint:   Springer Nature Switzerland AG
Country of Publication:   Switzerland
Edition:   1st ed. 2021
Dimensions:   Height: 254mm,  Width: 178mm, 
Weight:   295g
ISBN:   9783030591311
ISBN 10:   303059131X
Pages:   127
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
Case 1: Folliculotropic mycosis fungoides with central nervous system involvementCase 2: Erythema gyratum repens-like mycosis fungoides with large cell transformationCase 3: Eczema molluscatum in a patient with erythrodermic mycosis fungoidesCase 4: Parakeratosis variegata-like poikilodermatous CD8+ mycosis fungoidesCase 5: Parakeratosis variegata in a patient with CD8+ mycosis fungoides with post-inflammatory hypopigmentationCase 6: Poikilodermatous mycosis fungoidesCase 7: Tumor mycosis fungoides with xanthomatized atypical lymphocytesCase 8: CD20+ mycosis fungoides partially responsive to rituximabCase 9: Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS) in a patient with granulomatous mycosis fungoides and multiple tumorsCase 10. Folliculotropic mycosis fungoides with exuberant neutrophil-rich scale and follicular plugging mimicking hypertrophic actinic keratosisCase 11. Small plaque parapsoriasis-like mycosis fungoidesCase 12. Extragenital lichen sclerosus et atrophicans mimicking hypopigmented mycosis fungoidesCase 13: T-cell-rich angiomatoid polypoid pseudloymphoma (TRAPP) of the skinCase 14. Pustular Sezary syndromeCase 15. De novo expression of CD26 on Sezary cells as an indicator of the disease progression in a patient with Sezary syndromeCase 16. Sezary syndrome presenting with papuloerythroderma of Ofuji and leonine faciesCase 17. Mycosis fungoides-like presentation of primary cutaneous anaplastic large cell lymphomaCase 18. Anaplastic lymphoma kinase-positive primary cutaneous anaplastic large cell lymphomaCase 19. Successful treatment of primary cutaneous anaplastic large cell lymphoma on the penile shaft with brentuximab vedotin and allogenic stem cell transplantCase 20. Lymphomatoid papulosis type D in a child with CD8+ hypopigmented mycosis fungoidesCase 21. Lymphomatoid papulosis and autoimmunityCase 22. Infusion-related CD30-positive lymphomatoid drug eruption secondary to melphalanCase 23. Arthropod reaction with CD30 positive infiltrate and ulceration mimicking CD30 lymphoproliferative disorderCase 24: Extranodal NK/T-cell lymphoma, nasal typeCase 25. EBV-associated extranodal NK/T-cell lymphoma with / TCR expression presented as aphthous stomatitisCase 26. Extranodal NK/T-cell lymphoma, extra-nasal typeCase 27: Disseminated extranodal NK/T-cell lymphomaCase 28. Primary cutaneous T-cell lymphoma with mycosis fungoides-like plaquesCase 29. Indolent primary cutaneous T-cell lymphoma mimicking mycosis fungoidesCase 30. Primary cutaneous T-cell lymphoma with poor response to the therapyCase 31. Primary cutaneous unilateral non-cytotoxic T-cell lymphoma slowly progressing into tumorsCase 32. Primary cutaneous T cell lymphoma with panniculitis-like presentationCase 33: Primary cutaneous aggressive epidermotropic CD8-positive T-cell lymphoma with initial protracted courseCase 34. Primary cutaneous aggressive epidermotropic T-cell lymphoma (PC-AETCL) with an aberrant immune phenotypeCase 35. CD8+ T-cell lymphoma with cytotoxic phenotypeCase 36. Primary cutaneous aggressive epidermotropic T-cell lymphoma as a composite lymphoma with B-cell chronic lymphocytic leukemiaCase 37: Primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma with bullous manifestationCase 38. Leukemoid reaction mimicking aggressive epidermotropic CD8+ T-cell lymphomaCase 39. Cutaneous relapse of peripheral T-cell lymphoma, NOS by extensionCase 40. Generalized lymphadenopathy and poikiloderma due to prolonged interferon- -1b therapy misdiagnosed as peripheral T-cell lymphomaCase 41: Adult T-Cell Leukemia/LymphomaCase 42. Cutaneous Epstein-Barr Virus post-transplant lymphoproliferative disorderCase 43. Primary cutaneous CD30 T-cell posttransplant lymphoproliferative disorder with expressionCase 44. Primary cutaneous marginal zone lymphoma presented as facial patches unresponsive to rituximabCase 45. Primary cutaneous diffuse large B-cell lymphoma, leg type presenting on the scalpCase 46. Bruise-like nodules of blastic plasmacytoid dendritic cell neoplasm on the background of diffuse petechiaeCase 47: Blastic plasmacytoid dendritic cell neoplasm presented with deep purple nodulesCase 48: A solitary nodule of blastic plasmacytoid dendritic cell neoplasm in a young patientCase 49. A relapse of T-cell large granular lymphocytic (LGL) leukemia with chronic NK lymphocytosis in the skinCase 50. Indeterminate dendritic cell histiocytosisCase 51. A unique presentation of hemophagocytic lymphohistiocytosis with ulcerating papulonodules

Dr. Akilov is an Assistant Professor at the Department of Dermatology and a Director of Cutaneous Lymphoma Program at the University of Pittsburgh. 60% of his time devoted to clinical work when he sees the patient in the outpatient setting as well as a consulting physician for inpatient dermatology cases. Dr. Akilov is a principal investigator on various clinical trials in cutaneous lymphoma. As an independent investigator, Dr. Akilov's research focuses on the pathogenesis of mycosis fungoides and Sezary syndrome, biomarker discovery, and novel therapeutics and is supported by private foundations and pharmaceutical companies. Dr. Akilov is an active national and international teacher giving more than 20 lectures a year. Dr. Akilov serves on the Board of Directors of the United States Cutaneous Lymphoma Consortium. Dr. Akilov authored more than 70 publications in peer-reviewed journals, including around 40 on the subject of cutaneous lymphoma, three book chapters, and more than 200 of conference abstracts and proceedings.

See Also